[AKRO] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
08-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -29.86%
YoY- -83.33%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -72,705 -39,659 -35,542 -24,330 -21,403 -15,554 -11,148 36.64%
Tax 0 8,732 -549 -51 -6 -16,309 0 -
NP -72,705 -39,659 -34,993 -24,330 -21,403 -15,554 -11,148 36.64%
Tax Rate - - - - - - - -
Total Cost 72,705 39,659 34,993 24,330 21,403 15,554 11,148 36.64%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -1.05 -0.71 -0.91 -0.70 -0.63 -0.56 -0.53 12.05%
EPS Diluted -1.05 -0.71 -0.91 -0.70 -0.63 -0.56 -0.53 12.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.